Skip to content
Use caution Drug recall · FDA · Published April 2, 2025

Haloperidol Decanoate Injection Recall: Bacterial Contamination Risk

Amerisource Health Services recalls Haloperidol Decanoate Injection due to bacterial contamination in some units. This injectable medication poses a risk of infection if used.

🇺🇸 FDA recall #D-0368-2025DrugSomerset Therapeutics ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

Amerisource Health Services is recalling Haloperidol Decanoate Injection vials that may contain bacterial contamination. Using these vials could lead to infection, especially since they are prescription-only medications. Read more at govinfonow.com/recall/32160-haloperidol-decanoate-injection-recall-bacterial-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32160-haloperidol-decanoate-injection-recall-bacterial-contamination-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0368-2025

Cite this page

“Haloperidol Decanoate Injection Recall: Bacterial Contamination Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32160-haloperidol-decanoate-injection-recall-bacterial-contamination-risk. Based on FDA recall #D-0368-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0368-2025%22&limit=1).

The FDA announced on April 2, 2025, that Amerisource Health Services LLC is recalling Haloperidol Decanoate Injection due to a lack of sterility assurance and detected bacterial contamination. The voluntary Class II recall affects 14,189 vials distributed nationwide.

How to tell if you have it

  • Brand: Somerset Therapeutics
  • Product: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial
  • NDC: 68001-581-41
  • Lot code: A240482A
  • Expiration date: 08/31/2026

The hazard

The recall cites a lack of assurance of sterility, with bacterial contamination detected in some media fill units. The FDA classifies this as a Class II recall.

Context

GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since July 27, 2022. Recent actions include a May 1, 2026, recall for Primidone Tablets due to cross-contamination risk and a March 16, 2026, recall for Meclizine 12.5mg Tablets over failed specifications. Other recent recalls of similar products include a July 1, 2026, Victory Medical Center Pharmacy Glutathione Vials Recall for bacterial contamination risk and an Oct. 15, 2025, ProRx Semaglutide Injection Recall for contamination risk.

How to tell if you have this one

Check for the product name 'Haloperidol Decanoate Injection, 100 mg/mL, 1 x 1 mL Single-Dose Vial' with NDC 68001-581-41. The vials were manufactured by Somerset Therapeutics in India and distributed by Amerisource Health Services.

  • Brand
    Somerset Therapeutics
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA
  • NDC
    68001-579-59, 68001-579-48, 68001-580-41, 68001-581-41, 68001-581-48, 68001-581-82, 68001-578-59, 68001-578-48, 68001-582-41
Recall numberProduct, codes & lotsQuantity
D-0367-2025Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.; A240467B, EXP 07/31/20262,110 vials
D-0368-2025Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for BluePoint Laboratories, NDC 68001-581-41.; A240482A, EXP 08/31/202614,189 vials
D-0369-2025Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48.; A240482B, EXP 08/31/2026143 1x5 vials
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label includes NDC 68001-581-41 and was manufactured by Somerset Therapeutics.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 28 days after the firm started it.

1. Firm started the recall: Apr 2, 202512. FDA classified it Class II: Apr 18, 202523. Published in FDA’s Enforcement Report: Apr 30, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates bacterial contamination was detected in some units, so it is not safe to use without checking the recall status.

Similar recalls

Other Somerset Therapeutics recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0368-2025 (April 2, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0368-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA